To further confirm that YAP1 knockdown induces AD-like lesions and cognitive dysfunction through upregulation of Nr4a1 expression, we investigated whether reducing Nr4a1 levels could rescue the AD-like lesions associated with YAP1 deficiency in vivo. Here, NR4A1 is linked to Alzheimer disease.